UROV · Urovant Sciences
Acquired Company
Sumitovant Biopharma completed the acquisition of Urovant Sciences on 3/29/2021 for $16.25 per share in cash, representing an approximate equity value of $584 million.
Medicinal and Botanical Manufacturing
Manufacturing
Market Cap
1.018B
52 Wk Range
N/A - N/A
Previous Close
$16.24
Open
$16.24
Volume
N/A
Day Range
$16.24 - $16.24
Enterprise Value
N/A
Cash
159.3M
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
Mar 31st 2025